Athira Free Cash Flow Yield vs Free Cash Flow Per Share Analysis

ATHA Stock  USD 0.58  0.03  5.45%   
Athira Pharma financial indicator trend analysis is way more than just evaluating Athira Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Athira Pharma is a good investment. Please check the relationship between Athira Pharma Free Cash Flow Yield and its Free Cash Flow Per Share accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Athira Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.

Free Cash Flow Yield vs Free Cash Flow Per Share

Free Cash Flow Yield vs Free Cash Flow Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Athira Pharma Free Cash Flow Yield account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Athira Pharma's Free Cash Flow Yield and Free Cash Flow Per Share is 0.97. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of Athira Pharma, assuming nothing else is changed. The correlation between historical values of Athira Pharma's Free Cash Flow Yield and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Athira Pharma are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of Free Cash Flow Yield i.e., Athira Pharma's Free Cash Flow Yield and Free Cash Flow Per Share go up and down completely randomly.

Correlation Coefficient

0.97
Relationship DirectionPositive 
Relationship StrengthVery Strong

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.
Most indicators from Athira Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Athira Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Athira Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.As of December 22, 2024, Selling General Administrative is expected to decline to about 17.8 M. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation479K845K969K631.1K
Cost Of Revenue479K1.0M969K899.2K

Athira Pharma fundamental ratios Correlations

0.780.60.631.00.770.97-0.94-0.590.630.950.880.450.480.790.990.950.841.0-0.950.940.94-0.411.00.990.69
0.780.720.750.760.880.78-0.86-0.720.560.860.510.58-0.010.880.810.810.940.75-0.780.750.840.070.760.810.87
0.60.721.00.570.720.69-0.82-1.00.270.760.170.97-0.080.650.660.690.730.55-0.790.730.790.370.570.660.83
0.630.751.00.610.740.72-0.85-1.00.330.790.220.96-0.060.680.690.710.750.59-0.820.760.820.350.610.690.84
1.00.760.570.610.760.96-0.92-0.570.630.930.90.430.50.780.990.950.831.0-0.940.930.93-0.451.00.990.67
0.770.880.720.740.760.85-0.82-0.740.480.840.560.650.30.990.80.820.970.74-0.830.860.870.030.760.80.79
0.970.780.690.720.960.85-0.96-0.70.550.970.80.570.440.850.980.980.870.96-0.980.970.98-0.270.960.980.78
-0.94-0.86-0.82-0.85-0.92-0.82-0.960.82-0.52-0.99-0.66-0.7-0.21-0.81-0.96-0.96-0.87-0.910.97-0.93-0.980.1-0.92-0.96-0.87
-0.59-0.72-1.0-1.0-0.57-0.74-0.70.82-0.26-0.77-0.17-0.970.08-0.67-0.66-0.7-0.73-0.550.79-0.74-0.8-0.39-0.57-0.66-0.84
0.630.560.270.330.630.480.55-0.52-0.260.570.680.120.330.540.610.440.560.63-0.550.640.59-0.180.630.620.38
0.950.860.760.790.930.840.97-0.99-0.770.570.720.620.240.830.980.980.870.92-0.960.940.99-0.120.930.980.88
0.880.510.170.220.90.560.8-0.66-0.170.680.720.030.720.630.840.750.630.9-0.730.780.71-0.710.90.830.35
0.450.580.970.960.430.650.57-0.7-0.970.120.620.03-0.070.560.510.560.620.41-0.70.640.670.430.430.520.7
0.48-0.01-0.08-0.060.50.30.44-0.210.080.330.240.72-0.070.350.40.310.30.51-0.410.490.3-0.750.50.4-0.18
0.790.880.650.680.780.990.85-0.81-0.670.540.830.630.560.350.810.820.980.77-0.820.850.86-0.050.780.810.76
0.990.810.660.690.990.80.98-0.96-0.660.610.980.840.510.40.810.970.860.99-0.960.950.97-0.320.991.00.77
0.950.810.690.710.950.820.98-0.96-0.70.440.980.750.560.310.820.970.850.94-0.940.910.96-0.250.950.970.83
0.840.940.730.750.830.970.87-0.87-0.730.560.870.630.620.30.980.860.850.82-0.870.870.89-0.070.830.860.78
1.00.750.550.591.00.740.96-0.91-0.550.630.920.90.410.510.770.990.940.82-0.930.920.91-0.471.00.980.65
-0.95-0.78-0.79-0.82-0.94-0.83-0.980.970.79-0.55-0.96-0.73-0.7-0.41-0.82-0.96-0.94-0.87-0.93-0.98-0.980.2-0.94-0.96-0.77
0.940.750.730.760.930.860.97-0.93-0.740.640.940.780.640.490.850.950.910.870.92-0.980.97-0.210.930.950.74
0.940.840.790.820.930.870.98-0.98-0.80.590.990.710.670.30.860.970.960.890.91-0.980.97-0.090.930.970.87
-0.410.070.370.35-0.450.03-0.270.1-0.39-0.18-0.12-0.710.43-0.75-0.05-0.32-0.25-0.07-0.470.2-0.21-0.09-0.45-0.320.32
1.00.760.570.611.00.760.96-0.92-0.570.630.930.90.430.50.780.990.950.831.0-0.940.930.93-0.450.990.67
0.990.810.660.690.990.80.98-0.96-0.660.620.980.830.520.40.811.00.970.860.98-0.960.950.97-0.320.990.77
0.690.870.830.840.670.790.78-0.87-0.840.380.880.350.7-0.180.760.770.830.780.65-0.770.740.870.320.670.77
Click cells to compare fundamentals

Athira Pharma Account Relationship Matchups

Athira Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.2M279.6M332.0M258.2M160.2M190.1M
Short Long Term Debt Total1.6M1M1.9M1.9M1.6M1.6M
Other Current Liab852K3.0M8.1M18.3M28.0M29.4M
Total Current Liabilities1.3M4.4M9.3M21.4M28.8M30.3M
Total Stockholder Equity(19.7M)274.3M321.1M235.1M130.2M169.8M
Net Tangible Assets(19.7M)274.3M321.1M235.1M270.4M175.1M
Net Debt(503K)(59.6M)(108.6M)(94.1M)(89.0M)(93.4M)
Retained Earnings(21.1M)(41.0M)(95.9M)(191.5M)(309.2M)(293.7M)
Accounts Payable421K1.2M567K2.5M129K122.6K
Cash2.1M60.6M110.5M96.0M90.6M66.6M
Non Current Assets Total29K87.2M71.2M50.6M5.5M5.2M
Non Currrent Assets Other29K132K56K475K1.1M1.1M
Other Assets29K84.6M5.3M0.01.00.95
Cash And Short Term Investments2.1M184.7M253.8M200.3M147.4M145.4M
Net Receivables7K1.3M2.3M1.2M1.6M1.2M
Common Stock Shares Outstanding32.6M32.5M36.9M37.7M38.0M33.7M
Short Term Investments0.0124.1M143.2M104.4M56.8M78.8M
Liabilities And Stockholders Equity2.2M279.6M332.0M258.2M160.2M190.1M
Non Current Liabilities Total20.6M876K1.6M1.6M1.2M1.2M
Other Current Assets97K6.4M4.7M6.0M5.7M4.2M
Other Stockholder Equity1.4M315.3M417.4M428.6M439.7M294.0M
Total Liab21.9M5.3M10.9M23.0M30.1M20.4M
Net Invested Capital(18.2M)274.3M321.1M235.1M130.2M170.2M
Total Current Assets2.2M192.3M260.8M207.5M154.7M150.8M
Non Current Liabilities Other1.0M876K1.6M1.6M1.8M1.3M
Net Working Capital887K187.9M251.5M186.1M125.9M138.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Athira Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Athira Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Athira Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Athira Pharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Athira Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Athira Pharma. If investors know Athira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Athira Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.84)
Return On Assets
(0.48)
Return On Equity
(0.85)
The market value of Athira Pharma is measured differently than its book value, which is the value of Athira that is recorded on the company's balance sheet. Investors also form their own opinion of Athira Pharma's value that differs from its market value or its book value, called intrinsic value, which is Athira Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Athira Pharma's market value can be influenced by many factors that don't directly affect Athira Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Athira Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Athira Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Athira Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.